High serum S100A11 levels in EOC patients were closely related to tumor pathological stage, postoperative residual foci, ascites volume, serum CA125 level, platinum-based chemotherapy response, and lymph node metastasis (P < 0.05). This evidence concerns the gene S100A11 and neoplasm.